相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An Impedance-Based Cellular Assay Using Human iPSC-Derived Cardiomyocytes to Quantify Modulators of Cardiac Contractility
Clay W. Scott et al.
TOXICOLOGICAL SCIENCES (2014)
High-Throughput Multi-Parameter Profiling of Electrophysiological Drug Effects in Human Embryonic Stem Cell Derived Cardiomyocytes Using Multi-Electrode Arrays
Mike Clements et al.
TOXICOLOGICAL SCIENCES (2014)
Screening Drug-Induced Arrhythmia Events Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays
Enrique G. Navarrete et al.
CIRCULATION (2013)
Preservation of cardiomyocytes from the adult heart
Najah Abi-Gerges et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Calcium signalling of human pluripotent stem cell-derived cardiomyocytes
Sen Li et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
Phenotypic Profiling of Structural Cardiotoxins In Vitro Reveals Dependency on Multiple Mechanisms of Toxicity
Amy Pointon et al.
TOXICOLOGICAL SCIENCES (2013)
Comparison of Electrophysiological Data From Human-Induced Pluripotent Stem CellDerived Cardiomyocytes to Functional Preclinical Safety Assays
Kate Harris et al.
TOXICOLOGICAL SCIENCES (2013)
Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity
Oksana Sirenko et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Human induced pluripotent stem cells and their use in drug discovery for toxicity testing
Clay W. Scott et al.
TOXICOLOGY LETTERS (2013)
Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment
Yama A. Abassi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
In vitro Model for Assessing Arrhythmogenic Properties of Drugs Based on High-resolution Impedance Measurements
Filomain Nguemo et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2012)
Evaluation of Drugs With Specific Organ Toxicities in Organ-Specific Cell Lines
Zhiwu Lin et al.
TOXICOLOGICAL SCIENCES (2012)
Validation of an in vitro contractility assay using canine ventricular myocytes
A. R. Harmer et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
High throughput measurement of Ca2+ dynamics for drug risk assessment in human stem cell-derived cardiomyocytes by kinetic image cytometry
Fabio Cerignoli et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2012)
Muscle on a chip: In vitro contractility assays for smooth and striated muscle
Anna Grosberg et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2012)
High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents
Junyi Ma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Impedance-Based Detection of Beating Rhythm and Proarrhythmic Effects of Compounds on Stem Cell-Derived Cardiomyocytes
Malin K. B. Jonsson et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2011)
How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?
H. G. Laverty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Ensembles of engineered cardiac tissues for physiological and pharmacological study: Heart on a chip
Anna Grosberg et al.
LAB ON A CHIP (2011)
Cardiotoxicity Associated with Targeting Kinase Pathways in Cancer
Howard R. Mellor et al.
TOXICOLOGICAL SCIENCES (2011)
Estimating the Risk of Drug-Induced Proarrhythmia Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Liang Guo et al.
TOXICOLOGICAL SCIENCES (2011)
Functional Cardiotoxicity Profiling and Screening Using the xCELLigence RTCA Cardio System
Biao Xi et al.
JALA (2011)
An introduction to QT interval prolongation and non-clinical approaches to assessing and reducing risk
C. E. Pollard et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
Adriana Albini et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Altered cytosolic Ca2+ dynamics in cultured Guinea pig cardiomyocytes as an in vitro model to identify potential cardiotoxicants
Jian-Yong Qian et al.
TOXICOLOGY IN VITRO (2010)
Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates
Judith K. Gwathmey et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
In Vitro Electrophysiological Drug Testing Using Human Embryonic Stem Cell Derived Cardiomyocytes
Oren Caspi et al.
STEM CELLS AND DEVELOPMENT (2009)
Absence of Transverse Tubules Contributes to Non-Uniform Ca2+ Wavefronts in Mouse and Human Embryonic Stem Cell-Derived Cardiomyocytes
Deborah K. Lieu et al.
STEM CELLS AND DEVELOPMENT (2009)
Validation of a guinea pig Langendorff heart model for assessing potential cardiovascular liability of drug candidates
Liang Guo et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2009)
Strategies to reduce the risk of drug-induced QT interval prolongation: a pharmaceutical company perspective
C. E. Pollard et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition
Thomas Force et al.
NATURE REVIEWS CANCER (2007)
Drug-induced cardiovascular disorders
C. Aengus Murphy et al.
DRUG SAFETY (2007)
The use of receiver operating characteristic curves in biomedical informatics
TA Lasko et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2005)
Artifactual contractions triggered by field stimulation of cardiomyocytes
J Bokenes et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Differentiation of human embryonic stem cells to cardiomyocytes - Role of coculture with visceral endoderm-like cells
C Mummery et al.
CIRCULATION (2003)
分享论文
